Bone metastases and lung cancer recurrence on 99mTc-depreotide imaging

Hellenic Journal of Nuclear Medicine

Volumn 11, Issue 3, 2008, Pages 185-186

  Meristoudis, Georgios ^a,c   Ilias, Ioannis ^b   Batsakis, Christos ^a   Christakopoulou, Julia ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b HELENA VENIZELOU HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEPREOTIDE TC 99M; MEDRONATE TECHNETIUM TC 99M; SOMATOSTATIN RECEPTOR;

ADULT; BONE METASTASIS; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; HUMAN; LETTER; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; POSTOPERATIVE PERIOD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY IMAGING;

BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SOMATOSTATIN; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60849089365     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Sobic-Saranovic D, Pavlovic S, Jovanovic D et al. Assessment of non-small cell lung cancer viability and necrosis with three radiopharmaceuticals. Hell J Nucl Med 2008; 11: 16-20.
2. Axelsson R, Herlin G, Bååth M et al. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer. Acta Radiol 2008; 49: 295-302.
3. Tzannou IA, Karapanagiotou EM, Charpidou A et al. The use of radiolabeled somatostatin analog scintigraphy in the staging of small cell lung cancer patients. Am J Clin Oncol 2007; 30: 503-506.
4. 18F-FDG PET. Nucl Med Commun 2006; 27: 507-514.
5. 18F-fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest 2004; 125: 494-501.
6. 99mTc-depreotide in patients with lung cancer. Eur J Nucl Med Mol Imaging 2005; 32: 925-931.
7. 99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer. Eur J Nucl Med Mol Imaging 2004; 31: 1399-1404.
8. 99mTc depreotide scintigraphy. Clin Nucl Med 2002; 27: 410-412.
9. Bogot NR, Quint LE. Imaging of recurrent lung cancer. Cancer Imaging 2004; 4: 61-67.
10. Hellwig D, Gröschel A, Graeter TP et al. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2006; 33: 13-21.